Sustainable production of radionuclidically pure antimony-119
Abstract Background Radiopharmaceutical therapy (RPT) uses radionuclides that decay via one of three therapeutically relevant decay modes (alpha, beta, and internal conversion (IC) / Auger electron (AE) emission) to deliver short range, highly damaging radiation inside of diseased cells, maintaining...
Saved in:
Main Authors: | Aeli P. Olson (Author), Francesca A. Verich (Author), Paul A. Ellison (Author), Eduardo Aluicio-Sarduy (Author), Robert J. Nickles (Author), Jason C. Mixdorf (Author), Todd E. Barnhart (Author), Jonathan W. Engle (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring a tristhione scorpionate ligand as a suitable chelator for the theranostic pair antimony-119 and antimony-117
by: Lorraine Gaenaelle Gé, et al.
Published: (2024) -
PET Imaging of the Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68
by: Hailey A. Houson, et al.
Published: (2022) -
Structure of human GPR119-Gs complex binding APD597 and characterization of GPR119 binding agonists
by: Ruixue Li, et al.
Published: (2024) -
Radionuclide Treatments
Published: (2017) -
Characterization and Stability of the Antimony-Quercetin Complex
by: Valcilaine Teixeira Barbosa, et al.
Published: (2019)